// App-Quantinova.ai

: Digital Droplet PCR for Minimal Residual Disease Assessment in Philadelphia-Positive Acute Lymphoblastic Leukemia Using IG/TR Genes and BCR/ABL1 as Markers. Preliminary Results of a Comparative Analysis

Researchers

Presenter

  • Marco Beldinanzi

Principal Investigators

  • Irene Della Starza

  • Deborah Cardinali

  • Vittorio Bellomarino

  • Loredana Elia

  • Mabel Matarazzo

  • Mariangela Di Trani

  • Sabina Chiaretti

  • Robin Foa

Medical Centers

  • GIMEMA foundation, Rome, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • Breakpoint Cluster Region

Drug/Treatment

  • Ponatinib

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved